医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New Frontier Health Inc’s United Family Healthcare Launches Online and Telephone Consultations During COVID-19 Outbreak

2020年02月24日 PM10:30
このエントリーをはてなブックマークに追加


 

BEIJING

New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider, United Family Healthcare (UFH), announced today that UFH has launched free online and telephone consultation services to its patients. The services cover over 30 specialties, including Family Medicine, Pediatrics, Obstetrics and Gynecology, Internal Medicine, Surgery, Oncology, and Psychology.

“As a healthcare provider, we take seriously our duty and responsibility to be continually available to our patients and communities,” said Ms. Roberta Lipson, CEO of NFH and founder of UFH. “By leveraging technology, we are able to provide our industry-leading care and expertise not only to our patients, but also to anyone who needs medical information and guidance during this difficult time. At the same time, our seven operating hospitals and 18 clinics across China are well-prepared to care for patients throughout the current challenges of the 2019 novel coronavirus (COVID-19) outbreak, and we are among a handful of private healthcare operators in China providing around-the-clock medical services during the epidemic.”

In the past week, hundreds of physicians from UFH facilities around the country have provided free online and telephone consultations to over 800 patients, with health talks on live-broadcasting video platforms such as Tencent and TikTok reaching more than 1.2 million people. Through these online and telephone consultations, UFH has managed to stay engaged with patients during this exceptional time by answering patients’ health-related questions and guiding patients to come to UFH hospitals if needed. Meanwhile, such consultations help UFH to reach a broader swathe of customers, providing care while also helping them experience UFH’s high quality services.

In addition, UFH, New Frontier Group, a China-focused investment group that sponsored the entity that created NFH, and their strategic partners have announced a donation to Leishenshan Hospital, Zhongnan Hospital of Wuhan University, and other institutions at the front lines of the fight against COVID-19. The donation of medical equipment and consumables includes 29 ICU ventilators with 750 breathing circuits and 32 breathing masks, 155,000 pairs of medical examination gloves, 50,000 N95 masks, 3,960 goggles, and 185 reusable face shields. These medical supplies will be sourced across China and around the globe by UFH’s experienced supply chain team and will be directly shipped to the recipient hospitals.

As previously announced, several UFH hospitals are designated by the government to operate fever care centers, allowing patients to be screened and, if necessary, transferred to designated COVID-19 treatment hospitals. These fever screening centers are separated by air flows and work flows from standard patient clinics, emergency rooms, and inpatient facilities to keep any potentially infected patients from impacting other patients or visitors. As such, nearly all UFH facilities and departments continue to offer services as needed for both inpatients and outpatients.

About New Frontier Health Corporation

New Frontier Health Corporation (NYSE: NFH) is the operator of United Family Healthcare (UFH), a leading private healthcare provider offering comprehensive premium healthcare services in China through a network of private hospitals and affiliated ambulatory clinics. UFH currently has nine hospitals and in total in operation or under construction in all four 1st tier cities and selected 2nd tier cities. Additional information may be found at www.ufh.com.cn.

Forward-Looking Statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, without limitation, UFH’s preparedness to address the outbreak; UFH’s ability to manage patient inflows; and UFH’s ability to prevent the spread of nCoV within its facilities. These forward-looking statements are not guarantees of future results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside NFH’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. For a discussion of such risks, please refer to NFH’s Form 20-F filed with the U.S. Securities and Exchange Commission on December 26, 2019. NFH undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200224005343/en/

CONTACT

Media 

Wenjing Liu 

Tel: +86(10)59277342

Email: liu.wenjing@ufh.com.cn

Harry Chang 

Tel: +852-9822-1806 

Email: harry@new-frontier.com

Investors 

ICR, LLC 

William Zima/Rose Zu 

Tel: +1-203-682-8200 

Email: bill.zima@icrinc.com/rose.zu@icrinc.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Jichi Medical University and CureApp, Inc.: The First Phase 3 Clinical Trials of “Digital Therapeutics” for Hypertension Begin in Japan
  • EUSA Pharmaとイタリアのパパ・ジョヴァンニ23世病院がSISCO研究でシルツキシマブ治療を受けたCOVID-19患者の中間解析データを発表
  • EUSA Pharma和意大利Papa Giovanni XXIII医院提供Siltuximab治疗COVID-19患者的SISCO研究中期分析数据
  • Celltrion’s COVID-19 Antiviral Treatment Enters the Next Phase of Development
  • ‘Oracle Water’ Delivers Remarkable Ability of Effectively Sterilizing COVID-19